138 related articles for article (PubMed ID: 9878559)
1. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
[TBL] [Abstract][Full Text] [Related]
2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
[TBL] [Abstract][Full Text] [Related]
4. A partial agonist model used in the allosteric modulation of the NMDA receptor.
Robichon R; Randall PK; Leslie SW
Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
[TBL] [Abstract][Full Text] [Related]
6. Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits.
Kendrick SJ; Lynch DR; Pritchett DB
J Neurochem; 1996 Aug; 67(2):608-16. PubMed ID: 8764586
[TBL] [Abstract][Full Text] [Related]
7. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
8. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
9. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
Balcar VJ; Dias LS; Li Y; Bennett MR
Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
[TBL] [Abstract][Full Text] [Related]
11. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
[TBL] [Abstract][Full Text] [Related]
13. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on binding of 3 different ligands to the N-methyl-D-aspartate recognition domain in brain synaptic membranes treated with Triton X-100.
Zuo P; Ogita K; Han D; Yoneda Y
Brain Res; 1993 Apr; 609(1-2):253-61. PubMed ID: 8099522
[TBL] [Abstract][Full Text] [Related]
15. Two affinity states of N-methyl-D-aspartate recognition sites: modulation by cations.
Mukhin A; Kovaleva ES; London ED
J Pharmacol Exp Ther; 1997 Aug; 282(2):945-54. PubMed ID: 9262362
[TBL] [Abstract][Full Text] [Related]
16. Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonist--I. Pharmacological characterization in vitro.
Urwyler S; Laurie D; Lowe DA; Meier CL; Müller W
Neuropharmacology; 1996 Jun; 35(6):643-54. PubMed ID: 8887974
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
Dumont M; Lemaire S
Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
[TBL] [Abstract][Full Text] [Related]
18. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
Oblin A; Schoemaker H
Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain.
Mugnaini M; Giberti A; Ratti E; van Amsterdam FT
J Neurochem; 1993 Oct; 61(4):1492-7. PubMed ID: 8104234
[TBL] [Abstract][Full Text] [Related]
20. Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide.
Terse PS; Komiskey HL
Brain Res; 1997 Jan; 744(2):347-50. PubMed ID: 9027396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
